Clinical Trial Update: Escitalopram for the Treatment of Depression in Alzheimer's Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating escitalopram for depressive symptoms in Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Depressive Disorders

Drugs mentioned

• Escitalopram (escitalopram)

Snippet

Sponsor: Konkuk University Medical Center | Conditions: Alzheimer's Disease | Phase 4 | Status: COMPLETED